Cure My Disease

Don't miss your cure!

 Log in / Sign up

New heart procedure could reduce hospital stays for heart failure patients

NCT ID NCT07331220

Not yet recruiting Disease control Sponsor: Nanjing First Hospital, Nanjing Medical University Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 17 times

Summary

This study tests a procedure called pulmonary artery denervation (PADN) combined with standard medications versus a sham procedure with medications in 310 heart failure patients with preserved ejection fraction. The goal is to see if PADN reduces the risk of death, heart failure-related hospitalizations, or worsening symptoms. Participants will be followed for up to 24 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nanjing First Hospital, Nanjing Medical University

    Nanjing, Jiangsu, 210006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEART FAILURE WITH PRESERVED EJECTION FRACTION